Interacting Drugs |
Scopolamine (ophthalmic) vs OnabotulinumtoxinA |
Security Level |
 |
Mechanism |
OnabotulinumtoxinA: Anticholinergic Agents may enhance the anticholinergic effect of OnabotulinumtoxinA. |
Management |
Monitor therapy |
Scopolamine (ophthalmic) vs OnabotulinumtoxinA
Post Review about Scopolamine (ophthalmic) vs OnabotulinumtoxinA Click here to cancel reply.
Other Interactions of Scopolamine (ophthalmic)
Other Interactions of OnabotulinumtoxinA
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.